NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Peptobiotics

Peptobiotics

Private
SingaporeHealthcare & Life Scienceshttps://peptobiotics.com/

Last Round

Series A

Apr 9, 2024

Total Funding Raised

$6.38M

Company Overview

Peptobiotics is a biotechnology company that develops antimicrobial peptide technology to replace the use of antibiotics in agriculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Sustainable Materials, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

antimicrobial peptidesantibiotic alternativefeed additiveprecision fermentationsynthetic biologysynbioaquacultureagricultural biotechnologyag biotechanimal healthdrug resistanceaquatechrecombinant peptidesshrimp aquaculturelivestock feedgrowth promoterpeptide engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Peptobiotics Comparables

Compare Peptobiotics with similar companies based on industry and business-model similarity.

Peptobiotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Peptobiotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2024
GrantOct 27, 2022
SeedJan 1, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Jhee Hong Koh

Chief Technology Officer Cofounder

Founding Team

Marc Sohier

Chief Operating Officer

Executive Team

Peptobiotics Investors

Notable investors and investment history

Peptobiotics investors
InvestorRounds
Enterprise SingaporeGrant
SEEDS CapitalSeries A
Ponderosa VenturesSeed
Ponderosa VenturesSeries A
The Trendlines GroupSeed, Series A
The Yield Lab Asia PacificSeed, Series A
Entrepreneurs FirstSeed, Series A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 146% MoM, from 91 to 224.

  • Oct 24, 2024

    Monthly visitors grew 1048% MoM, from 21 to 241.

View all signals

Peptobiotics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Peptobiotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Peptobiotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range22
Year Founded2020
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.